CSBR vs SERA
Comparison between Champions Oncology Inc (CSBR, Company) and Sera Prognostics Inc Class A (SERA, Company).
Both CSBR and SERA are from the Healthcare sector.
5-Year PerformanceCSBR has outperformed SERA, delivering a return of -7.1% compared to -31.4%
CSBR vs SERA - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
CSBR vs SERA - Historical Returns
Returns include dividend reinvestment.
CSBR vs SERA - Annual Returns (2007 - 2026)
Returns include dividend reinvestment.
| Year | CSBR | SERA |
|---|---|---|
| 2026 | -6.16% | -38.33% |
| 2025 | -15.73% | -64.59% |
| 2024 | +48.01% | +36.35% |
| 2023 | +27.15% | +356.49% |
| 2022 | -46.82% | -83.57% |
| 2021 | -22.59% | -42.27% |
| 2020 | +32.56% | N/A |
| 2019 | +5.58% | N/A |
| 2018 | +94.28% | N/A |
| 2017 | +36.14% | N/A |
| 2016 | -33.07% | N/A |
| 2015 | -40.50% | N/A |
| 2014 | -58.33% | N/A |
| 2013 | +300.00% | N/A |
| 2012 | -60.00% | N/A |
| 2011 | -16.67% | N/A |
| 2010 | +12.50% | N/A |
| 2009 | -25.93% | N/A |
| 2008 | -20.00% | N/A |
| 2007 | +133.33% | N/A |
CSBR vs SERA Drawdown Comparison
The maximum drawdown for CSBR was -94.13%, occurring on Sep 16, 2016. This drawdown has not yet recovered.
The maximum drawdown for SERA was -91.10%, occurring on Dec 28, 2022. This drawdown has not yet recovered.
The current CSBR drawdown is -75.20%. The current SERA drawdown is -85.81%.
| Rank | CSBR | SERA |
|---|---|---|
| #1 | -94.13% Oct 24, 2007 - Sep 16, 2016 | -91.10% Aug 9, 2021 - Dec 28, 2022 |
| #2 | -58.33% Feb 2, 2007 - May 31, 2007 | -23.11% Jul 15, 2021 - Aug 2, 2021 |
| #3 | -35.71% Jun 1, 2007 - Oct 10, 2007 | -8.00% Aug 2, 2021 - Aug 5, 2021 |
| #4 | -12.71% Oct 18, 2007 - Oct 23, 2007 | N/A |
Correlation
Correlation between CSBR and SERA is 0.18 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks